HTC
Hershey Trust Company Portfolio holdings
AUM
$9.41B
This Quarter Return
+0.04%
1 Year Return
-0.34%
3 Year Return
-1.36%
5 Year Return
-1.34%
10 Year Return
+3.1%
AUM
$10.7B
AUM Growth
+$10.7B
(+10%)
Cap. Flow
+$19.2M
Cap. Flow
% of AUM
0.18%
Top 10 Holdings %
Top 10 Hldgs %
99.87%
Holding
42
New
7
Increased
7
Reduced
3
Closed
5
Top Buys
| 1 |
iShares MSCI EAFE Small-Cap ETF
SCZ
|
$13.4M |
| 2 |
Pinduoduo
PDD
|
$2.79M |
| 3 |
Teladoc Health
TDOC
|
$1.82M |
| 4 |
CRISPR Therapeutics
CRSP
|
$1.24M |
| 5 |
C3.ai
AI
|
$250K |
Top Sells
| 1 |
iShares Russell 2000 ETF
IWM
|
$2.75M |
| 2 |
Wayfair
W
|
$1.32M |
| 3 |
CMRC
Commerce.com, Inc. Series 1 Common Stock
CMRC
|
$1.32M |
| 4 |
Lemonade
LMND
|
$894K |
| 5 |
Repare Therapeutics
RPTX
|
$151K |
Sector Composition
| 1 | Healthcare | 0.11% |
| 2 | Consumer Staples | 0.08% |
| 3 | Consumer Discretionary | 0.03% |
| 4 | Technology | 0.01% |
| 5 | Communication Services | 0.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
OYST
26
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $152K | ﹤0.01% |
8,861
| – | – |
|
|
JNCE
27
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $149K | ﹤0.01% |
21,948
+12,058
| +122% | +$81.9K |
|
28
Aligos Therapeutics
ALGS
$73.3M
| $124K | ﹤0.01% |
+6,063
| New | +$124K |
|
|
EGRX
29
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $92K | ﹤0.01% |
2,138
| – | – |
|
30
Aprea Therapeutics
APRE
$9.12M
| $48K | ﹤0.01% |
9,822
| – | – |
|
31
Adverum Biotechnologies
ADVM
$64.6M
| $13K | ﹤0.01% |
3,710
| – | – |
|
|
NOAH
32
Noah Holdings
NOAH
$824M
| $12K | ﹤0.01% |
253
| – | – |
|
|
CMRC
33
Commerce.com, Inc. Series 1 Common Stock
CMRC
$375M
| – | – |
-22,766
| Closed | -$1.32M |
|
34
Glaukos
GKOS
$5.5B
| – | – |
-983
| Closed | -$83K |
|
|
35
Lemonade
LMND
$3.91B
| – | – |
-9,596
| Closed | -$894K |
|
|
36
Wayfair
W
$9.67B
| – | – |
-4,203
| Closed | -$1.32M |
|
|
MRO
37
DELISTED
Marathon Oil Corporation
MRO
| – | – |
-134
| Closed | -$1K |
|